Want to see HK:1345 full AI Analyst Report?
1345 Stock Chart & Stats
HK$2.24
-HK$0.01(-0.45%)
At close: 4:00 PM EDT
HK$2.24
-HK$0.01(-0.45%)
Day’s Range― - ―
52-Week RangeHK$1.84 - HK$2.40
Previous CloseN/A
Volume69.00K
Average Volume (3M)28.27K
Market Cap
HK$2.64B
Enterprise ValueHK$2.60K
Total Cash (Recent Filing)HK$159.15M
Total Debt (Recent Filing)HK$218.01M
Price to Earnings (P/E)17.6
Beta0.16
Next Earnings
Mar 29, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield5.45%
Share Statistics
EPS (TTM)0.11
Shares Outstanding1,257,447,000
10 Day Avg. Volume18,500
30 Day Avg. Volume28,266
Financial Highlights & Ratios
PEG Ratio-0.90
Price to Book (P/B)2.33
Price to Sales (P/S)1.90
P/FCF Ratio12.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLow leverage and a substantial equity base reduce financial strain and preserve flexibility for investment or resilience. This conservative funding structure is a durable support even while operating performance is uneven.
Recent Cash GenerationPositive operating cash flow and improving free cash flow indicate the business is currently converting operations into funding. Sustained cash generation can support reinvestment, obligations and shareholder returns without relying heavily on external capital.
Healthy Underlying Product EconomicsA gross margin near 49% provides a meaningful buffer for operating costs and competitive pressures. Although profitability has weakened, the underlying product economics remain solid and could support recovery if demand stabilizes.
Bears Say
Declining Revenue TrendThe latest revenue contraction signals weaker demand or market execution in the core business. A sustained top-line decline can reduce operating leverage, constrain reinvestment and make recovery in earnings more dependent on cost control.
Reduced Profitability And ReturnsLower margins and declining return on equity indicate that the company is using its resources less efficiently than at its 2022 peak. If this persists, weaker earnings quality may limit internal capital generation and strategic flexibility.
Volatile Cash ConversionRecent cash generation is encouraging, but the history of negative operating and free cash flow shows inconsistent conversion from earnings to cash. Variability can complicate planning and reduce confidence that reported profitability will consistently fund obligations.
Shanghai Pioneer Holding Ltd News
1345 FAQ
What was Shanghai Pioneer Holding Ltd’s price range in the past 12 months?
Shanghai Pioneer Holding Ltd lowest stock price was HK$1.84 and its highest was HK$2.40 in the past 12 months.
What is Shanghai Pioneer Holding Ltd’s market cap?
Shanghai Pioneer Holding Ltd’s market cap is HK$2.64B.
When is Shanghai Pioneer Holding Ltd’s upcoming earnings report date?
Shanghai Pioneer Holding Ltd’s upcoming earnings report date is Mar 29, 2027 which is in 184 days.
How were Shanghai Pioneer Holding Ltd’s earnings last quarter?
Shanghai Pioneer Holding Ltd released its earnings results on Aug 28, 2026. The company reported HK$0.056 earnings per share for the quarter.
Is Shanghai Pioneer Holding Ltd overvalued?
According to Wall Street analysts Shanghai Pioneer Holding Ltd’s price is currently Overvalued.
Does Shanghai Pioneer Holding Ltd pay dividends?
Shanghai Pioneer Holding Ltd pays a Semiannually dividend of HK$0.056 which represents an annual dividend yield of 5.45%. See more information on Shanghai Pioneer Holding Ltd dividends here
What is Shanghai Pioneer Holding Ltd’s EPS estimate?
Shanghai Pioneer Holding Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shanghai Pioneer Holding Ltd have?
Shanghai Pioneer Holding Ltd has 1,257,447,000 shares outstanding.
What happened to Shanghai Pioneer Holding Ltd’s price movement after its last earnings report?
Shanghai Pioneer Holding Ltd reported an EPS of HK$0.056 in its last earnings report. Following the earnings report the stock price went up 4.186%.
Which hedge fund is a major shareholder of Shanghai Pioneer Holding Ltd?
Currently, no hedge funds are holding shares in HK:1345
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Shanghai Pioneer Holding Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
17.39%
12-Months-Change
Fundamentals
Return on Equity
5.45%
Trailing 12-Months
Asset Growth
20.34%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Shanghai Pioneer Holding Ltd
China Pioneer Pharma Holdings Limited operates as an investment holding company, primarily focusing on the marketing, promotion, and distribution of pharmaceutical goods and medical devices within mainland China. The firm maintains an extensive portfolio of pharmaceutical products addressing diverse therapeutic areas, including ophthalmology, pain management, cardiovascular health, immunology, gynecology, and gastroenterology. Its medical device offerings encompass solutions for ophthalmology, orthopedics, dentistry, and wound care. The company supplies its products to a wide client base, including hospitals, various medical institutions, and pharmacies. Additionally, it engages in the sale of supporting tools, leases related equipment, provides dental apparatus, and distributes imported prescription products under license. Established in 1996, China Pioneer Pharma Holdings Limited is headquartered in Shanghai, PRC, and functions as a subsidiary of Pioneer Pharma (BVI) Co., Ltd.
Technical Analysis
Peijia Medical Ltd.
―
Acotec Scientific Holdings Limited
―
MicroPort CardioFlow Medtech Corp.
―
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H
―
Zhejiang Taimei Medical Technology Co Ltd Class H
―